Updated findings from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study (NCT04221945) show the survival advantages of ...

Keytruda contains the active ingredient pembrolizumab. (An active ingredient is what makes a drug work.) Keytruda is a biologic medication. A biologic is made from parts of living organisms.

Carter received the second such drug, pembrolizumab, which was authorized ... "The best favor you can do for a famous patient ...

It is a treatment that does not kill cancer cells itself but instead stimulates the body's immune system to attack them. Pembrolizumab ... But it may not work for everyone. In people with advanced ...

For basal cell carcinomas and squamous cell carcinomas, surgery (excision) or electrodesiccation and cautery of the cancer is ...

As a result, NICE has said that the results of the KEYNOTE-048 clinical trial, which grouped all forms of head and neck cancer together irrespective of their location and used the three-drug cocktail ...

I asked whether he worries that the work could lead to editing embryos for traits that parents prize. He flicked his hand in exasperation. “I don’t do gene editing. I don’t do manipulation ...

Scientists are learning how cancer cells outwit cutting-edge cancer therapies like checkpoint inhibitors—and developing ...

“We know [immunotherapy] can work in untreated or previously treated but ... in a review of the topic at the recent World Conference on Lung Cancer. But how does a large molecule, like pembrolizumab, ...

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their ...

@hopkinskimmel investigators develop computational tool to predict immunotherapy outcomes for patients with metastatic ...

ALPMF's expanding lineup of cancer drugs, including zolbetuximab, positions them for substantial market growth and potential appreciation.